Great Lakes Advisors’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-31,348
Closed -$954K 839
2024
Q1
$954K Sell
31,348
-981
-3% -$32.9K 0.01% 553
2023
Q4
$1.15M Sell
32,329
-38,508
-54% -$1.43M 0.01% 513
2023
Q3
$3.1M Sell
70,837
-3,905
-5% -$191K 0.03% 400
2023
Q2
$3.69M Sell
74,742
-7,652
-9% -$353K 0.04% 386
2023
Q1
$3.42M Buy
+82,394
New +$3.42M 0.03% 430
2022
Q2
Sell
-4,683
Closed -$308K 678
2022
Q1
$308K Buy
4,683
+37
+0.8% +$2.4K 0.01% 593
2021
Q4
$323K Buy
4,646
+1,322
+40% +$96.1K ﹤0.01% 567
2021
Q3
$231K Buy
+3,324
New +$256K ﹤0.01% 630
2019
Q2
Sell
-7,684
Closed -$206K 532
2019
Q1
$206K Buy
+7,684
New +$233K ﹤0.01% 556

Other funds holding ATRC

Great Lakes Advisors's ATRC Position: Q2 2024 in Review

Great Lakes Advisors sold out of AtriCure (ATRC) in Q2 2024, closing a stake of 31,348 shares — an estimated $954K sold.

Great Lakes Advisors first reported a position in ATRC in Q1 2019 and held it in 9 quarters. The position peaked at $3.69M in Q2 2023. 197 funds tracked by Wall St. Rank hold ATRC as of Q2 2024.

  • Great Lakes Advisors reported no remaining AtriCure position as of Q2 2024 after selling out during the quarter.
  • Great Lakes Advisors sold 31,348 AtriCure shares in Q2 2024, an estimated $954K.
  • Great Lakes Advisors first reported a position in AtriCure in Q1 2019 and held it in 9 quarters.
  • Great Lakes Advisors's AtriCure position peaked at $3.69M in Q2 2023.
  • 197 funds tracked by Wall St. Rank held AtriCure as of Q2 2024.

Based on Great Lakes Advisors's 13F filing for Q2 2024, filed 6 Aug 2024.